Allosensitization in heart transplanted patients after prior therapy with Ventricular Assist Device: 20 years of experience

Dr. Lilly Ilcheva discusses the impact of allosensitization in heart transplant patients post-VAD therapy, drawing from a 20-year study (2004-2024), examining antibody development, transplant outcomes, and survival rates.

Quo Vadis Aortic Surgery ?

Prof. Schmidli introduces Prof. Senning's pioneering cardiac work, discusses mortality rates in AAA, Bern's OAR experience, aortic arch procedures, graft infections, and future innovations, emphasizing training and simulation for future surgeons.

Cannulation test: Step-by-Step Guide

Reconsidering current approaches to valve and LVAD therapies

Edwards Lifesciences - Innovations in Cardiac Surgery: Exploring INSPIRIS RESILIA Aortic valve, Endocarditis Prevention, and the Role of Cerbral Oximetry

Prim. Prof. Dr. Martin Grabenwöger

Edwards Lifesciences - The Heart Team - What is the added value for the patient?

Prof. Wenaweser / Prof. Grunenfelder / Prof. Gamperli / Prof. Corti

Edwards Lifesciences Interview - How did we build a Heart Team?

Prof. Wenaweser / Prof. Grunenfelder / Prof. Gamperli / Prof. Corti

Edwards Lifesciences Interview - Why a Heart Team?

Prof. Wenaweser / Prof. Grunenfelder / Prof. Gamperli / Prof. Corti

Edwards Lifesciences - EDWARDS INTUITY Elite Valve System: How to achieve Surgical Success, from selection to techniques

Prof. Günther Laufer